van Dam-Nolen Dianne H K, Truijman Martine T B, van der Kolk Anja G, Liem Madieke I, Schreuder Floris H B M, Boersma Eric, Daemen Mat J A P, Mess Werner H, van Oostenbrugge Robert J, van der Steen Antonius F W, Bos Daniel, Koudstaal Peter J, Nederkoorn Paul J, Hendrikse Jeroen, van der Lugt Aad, Kooi M Eline
Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands; Department of Neurology, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
Department of Neurology, CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, the Netherlands.
JACC Cardiovasc Imaging. 2022 Oct;15(10):1715-1726. doi: 10.1016/j.jcmg.2022.04.003. Epub 2022 Jun 15.
Patients with symptomatic carotid stenosis are at high risk for recurrent stroke. The decision for carotid endarterectomy currently mainly relies on degree of stenosis (cutoff value >50% or 70%). Nevertheless, also, patients with mild-to-moderate stenosis still have a considerable recurrent stroke risk. Increasing evidence suggests that carotid plaque composition rather than degree of stenosis determines plaque vulnerability; however, it remains unclear whether this also provides additional information to improve clinical decision making.
The PARISK (Plaque At RISK) study aimed to improve the identification of patients at increased risk of recurrent ischemic stroke using multimodality carotid imaging.
The authors included 244 patients (71% men; mean age, 68 years) with a recent symptomatic mild-to-moderate carotid stenosis in a prospective multicenter cohort study. Magnetic resonance imaging (carotid and brain) and computed tomography angiography (carotid) were performed at baseline and after 2 years. The clinical endpoint was a recurrent ipsilateral ischemic stroke or transient ischemic attack (TIA). Cox proportional hazards models were used to assess whether intraplaque hemorrhage (IPH), ulceration, proportion of calcifications, and total plaque volume in ipsilateral carotid plaques were associated with the endpoint. Next, the authors investigated the predictive performance of these imaging biomarkers by adding these markers (separately and simultaneously) to the ECST (European Carotid Surgery Trial) risk score.
During 5.1 years follow-up, 37 patients reached the clinical endpoint. IPH presence and total plaque volume were associated with recurrent ipsilateral ischemic stroke or TIA (HR: 2.12 [95% CI: 1.02-4.44] for IPH; HR: 1.07 [95% CI: 1.00-1.15] for total plaque volume per 100 µL increase). Ulcerations and proportion of calcifications were not statistically significant determinants. Addition of IPH and total plaque volume to the ECST risk score improved the model performance (C-statistics increased from 0.67 to 0.75-0.78).
IPH and total plaque volume are independent risk factors for recurrent ipsilateral ischemic stroke or TIA in patients with mild-to-moderate carotid stenosis. These plaque characteristics improve current decision making. Validation studies to implement plaque characteristics in clinical scoring tools are needed. (PARISK: Validation of Imaging Techniques [PARISK]; NCT01208025).
有症状的颈动脉狭窄患者发生复发性卒中的风险很高。目前,颈动脉内膜切除术的决策主要依赖于狭窄程度(临界值>50%或70%)。然而,轻度至中度狭窄的患者仍有相当高的复发性卒中风险。越来越多的证据表明,颈动脉斑块的成分而非狭窄程度决定了斑块的易损性;然而,这是否也能提供额外信息以改善临床决策仍不清楚。
PARISK(斑块风险)研究旨在通过多模态颈动脉成像改善对复发性缺血性卒中风险增加患者的识别。
在一项前瞻性多中心队列研究中,作者纳入了244例近期有症状的轻度至中度颈动脉狭窄患者(71%为男性;平均年龄68岁)。在基线和2年后进行磁共振成像(颈动脉和脑部)及计算机断层血管造影(颈动脉)检查。临床终点为同侧复发性缺血性卒中和短暂性脑缺血发作(TIA)。采用Cox比例风险模型评估同侧颈动脉斑块内出血(IPH)、溃疡、钙化比例和总斑块体积是否与终点事件相关。接下来,作者通过将这些标志物(单独和同时)添加到欧洲颈动脉外科试验(ECST)风险评分中,研究了这些成像生物标志物的预测性能。
在5.1年的随访期间,37例患者达到临床终点。IPH的存在和总斑块体积与同侧复发性缺血性卒中和TIA相关(IPH的风险比:2.12[95%置信区间:1.02 - 4.44];总斑块体积每增加100µL的风险比:1.07[95%置信区间:1.00 - 1.15])。溃疡和钙化比例不是有统计学意义的决定因素。将IPH和总斑块体积添加到ECST风险评分中可改善模型性能(C统计量从0.67增加到0.75 - 0.78)。
IPH和总斑块体积是轻度至中度颈动脉狭窄患者同侧复发性缺血性卒中和TIA的独立危险因素。这些斑块特征可改善当前的决策。需要进行验证研究以将斑块特征纳入临床评分工具。(PARISK:成像技术验证[PARISK];NCT01208025)